Introduction
============

Laser in situ keratomileusis (LASIK) is one of the most established corneal refractive surgeries in the world. The safety, efficacy, and predictability following LASIK are excellent.[@b1-opth-10-1859] Kato et al[@b2-opth-10-1859] reported that the uncorrected visual acuity (UCVA; logarithm of the minimum angle of resolution) of patients undergoing LASIK improved from 1.27 preoperatively to −0.08 at 1 month following surgery and remained stable up to 1 year after surgery. UCVAs (logarithm of the minimum angle of resolution) \>0.0 were obtained in 85% of patients at 1 month after surgery.[@b2-opth-10-1859] In a systematic review, Solomon et al[@b3-opth-10-1859] reported patient satisfaction rate after myopic LASIK to be 95.3% (1,811 of 1,901 patients). While there is strong evidence for visual function improvement following LASIK, it remains unclear whether LASIK also improves quality of life (QOL).[@b4-opth-10-1859],[@b5-opth-10-1859]

Health-related quality of life (HRQoL) includes physical and mental health perceptions (<http://www.cdc.gov/hrqol/concept.htm>). The 36-Item Short Form Health Survey (SF-36) is a multipurpose questionnaire that evaluates mental and physical aspects of HRQoL (<http://www.sf-36.org>). SF-36 is one of the most widely used and standardized questionnaires for evaluating HRQoL and is capable of dissecting the mental and physical aspects of QOL through calculation of mental component summary (MCS) and physical component summary (PCS) scores.[@b6-opth-10-1859]

The aims of our study were to investigate whether LASIK improves HRQoL and to identify factors that affect postoperative QOL, using the Japanese version of SF-36 Version 2 questionnaire.[@b7-opth-10-1859]

Materials and methods
=====================

This study's procedures conformed to the tenets of the Declaration of Helsinki and to national (Japanese) and institutional (Minamiaoyama Eye Clinic) regulations. The study was approved by the Ethics Committee of the Minamiaoyama Eye Clinic. All study subjects gave written informed consent prior to enrollment.

Subject enrollment
------------------

This is a prospective hospital-based study. A total of 213 Japanese patients (male 72 and female 141) who underwent primary LASIK at Minamiaoyama Eye Clinic between January 20, 2012, and June 6, 2013, were consecutively included and analyzed in this study. The demographic characteristics of the subjects are listed in [Table 1](#t1-opth-10-1859){ref-type="table"}. Of the 213 subjects who responded to the preoperative SF-36 questionnaire, 212 subjects (99.5%) responded to the SF-36 at 1 month after surgery and 114 subjects (53.5%) responded at 6 months. Among the 213 subjects, 203 subjects underwent conventional LASIK and ten subjects underwent topography-guided LASIK. We also conducted a subgroup analysis in which we excluded subjects with systemic diseases, including hypertension, Sjögren syndrome, and carcinomas, and ocular diseases, including glaucoma, atopic keratoconjunctivitis, and history of ocular surgery. In this subgroup analysis, 40 subjects were excluded and 173 healthy subjects were analyzed.

LASIK procedure
---------------

LASIK was performed on both eyes of each patient successively, using an identical method. A corneal flap was created with a femtosecond laser (IntraLase FS 60 or iFS; Abbott Laboratories, Abbott Park, IL, USA), and laser ablation was performed using an excimer laser, EC-5000 (NIDEK Co. Ltd., Aichi, Japan) or STAR S4IR (Abbott Laboratories). After surgery, antibiotic eyedrops (Cravit; Santen, Osaka, Japan) were prescribed five times per day and discontinued at 1 week postoperatively. We did not use topical steroid after surgery.

Preoperative and postoperative examination
------------------------------------------

Postoperative examinations were performed at the time of questionnaire response collection. All the subjects underwent slit lamp microscopy, including fundus examination, non-corrected visual acuity (NCVA) assessment, best-corrected visual acuity (BCVA) assessment, pupil diameter measurement (OPD-Scan II; NIDEK Co. Ltd.), and axial length measurement (IOLMaster 500; Carl Zeiss Meditec AG, Jena, Germany). The ocular surface was stained with 2 μL of 1% preservative-free fluorescein solution instilled into the conjunctival sac. Tear break-up time (BUT) was defined as the interval between the last complete blink and the first disturbance of the stained corneal tear film. Fluorescein staining was graded from 0 to 3 for each cornea, according to the extent of staining: 0, negative; 1, scattered minute; 2, moderate spotty; and 3, diffuse blotchy staining. We measured BUT and fluorescein staining preoperatively and 1 month after LASIK. The patients were asked to report any history of systemic or ocular disease and any medications they were taking before LASIK. The changes in NCVA, BCVA, BUT, and fluorescein scores are listed in [Table 2](#t2-opth-10-1859){ref-type="table"}.

Assessment of QOL, quality of vision, ocular symptoms, and satisfaction
-----------------------------------------------------------------------

QOL was assessed by the Japanese version of SF-36 Version 2, for which the reliability and validity have been reported with normative data, and is considered to be appropriate for those aged 20--70 years.[@b6-opth-10-1859],[@b7-opth-10-1859] Subjects were asked to answer each of the 36 questionnaire items in terms of the past 4 weeks. These 36 items related to the following eight scales of QOL: physical functioning, role-physical, bodily pain, general health perception, vitality, social functioning, role-emotional, and mental health. MCS and PCS scores were then calculated from these eight scale scores according to the manual. Delta MCS was calculated by subtracting the preoperative MCS value from the MCS value 1 month after LASIK. Delta PCS was calculated using the same method.

All participants were also asked to complete a separate questionnaire. We surveyed quality of vision and ocular symptoms 1 month after LASIK by asking questions about quality of far-vision, quality of near-vision, halo, glare, double vision, and asthenopia using a response scale of 0--4 (0= very good, 1= good, 3= bad, and 4= very bad). We also surveyed patient satisfaction with LASIK outcome 1 month and 6 months after surgery by asking patients to grade outcome satisfaction on a scale of 1--4 (1= very satisfied, 2= satisfied, 3= not very satisfied, and 4= not satisfied at all). The subjects who responded with 1 or 2 were defined as subjects who were satisfied. The satisfaction rate was calculated by dividing the number of subjects who were satisfied by the number of subjects who answered this question. QOL assessment and questionnaires were completed before LASIK and 1 month ±1 week and 6 months ±1 month after LASIK.

Statistical analysis
--------------------

A trend in change from baseline over 6 months in MCS, PCS, UCVA, spherical equivalent, BUT, and fluorescein scores before LASIK and 1 month and 6 months after LASIK was compared using a linear mixed-effects model. This model contains change from baseline at each time point as a response and month (degree of freedom =1) as a fixed effect and patient as a random effect.

In the univariate analysis, the correlation between preoperative MCS, delta MCS, and the preoperative factors age, NCVA, BCVA, spherical equivalent, axial length, pupil diameter, BUT, and fluorescein score was analyzed by Pearson's correlation coefficient or Spearman's correlation coefficient.

Multivariate analysis was used to investigate the association between preoperative factors and delta MCS. Specifically, delta MCS was treated as an independent variable in a linear regression model by adjusting for preoperative factors, including age, sex, axial length, presence of systemic disease, BUT, pupil diameter, and fluorescein score. To investigate the association between postoperative factors and delta MCS, we evaluated delta MCS as an independent variable using a linear regression model by adjusting for confounding factors, including age, sex, postoperative NCVA, spherical equivalent, BUT, fluorescein score, and postoperative symptoms.

PCS and delta PCS were also analyzed by the same method.

A *P*-value of \<0.05 was considered statistically significant. All statistical analyses were performed using SPSS software, Version 21 (IBM Corporation, Armonk, NY, USA).

Results
=======

Changes in MCS and PCS scores before and after LASIK are listed in [Table 3](#t3-opth-10-1859){ref-type="table"}. Compared with the preoperative score, the MCS score was significantly improved 1 month after surgery (*P*=0.03). However, no significant difference was observed between preoperative MCS score and MCS score 6 months after LASIK (*P*=0.99). Similar results were obtained when the analysis was restricted to healthy subjects, with significant MCS score improvement over preoperative baseline at 1 month after surgery (*P*=0.02). Again, no significant difference was observed between preoperative MCS score and MCS score 6 months after LASIK (*P*=0.99). No significant change was observed in the PCS score after LASIK (*P*=0.54) at either time point in either subject group.

In a univariate analysis, spherical equivalent (*r*=0.16, *P*=0.02 in the right eye; *r*=0.16, *P*=0.02 in the left eye) was correlated with delta MCS. In healthy subjects, spherical equivalent (*r*=0.22, *P*=0.005 in the right eye; *r*=0.21, *P*=009 in the left eye), axial length (*r*=−0.20, *P*=0.02 in the right eye; *r*=−0.25, *P*=0.002 in the left eye), and NCVA (*r*=−0.23, *P*=0.005 in the right eye; *r*=−0.25, *P*=0.002 in the left eye) were correlated with delta MCS. Other included factors were not correlated with delta MCS. No factor was correlated with PCS in either subject group.

In a stepwise multiple linear regression analysis, the association between delta MCS and preoperative factors was calculated and is listed in [Table 4](#t4-opth-10-1859){ref-type="table"}. Delta MCS was significantly related to preoperative spherical equivalent and axial length in both groups. Other factors were not associated with delta MCS. No preoperative factors were associated with delta PCS.

[Table 5](#t5-opth-10-1859){ref-type="table"} lists the associations between delta MCS and postoperative factors. The severity of halo, glare, double vision, and asthenopia were all negatively correlated with delta MCS. The satisfaction rate for LASIK was positively correlated with delta MCS. All included variables were significantly associated with delta MCS after adjustment for possible confounding factors. No postoperative factors were associated with delta PCS.

Discussion
==========

In this study, we showed that LASIK may improve mental HRQoL 1 month after surgery.

Some studies have shown that LASIK improves patients' QOL. Schein et al[@b8-opth-10-1859] evaluated the effect of LASIK on vision-related QOL using the questionnaire the Refractive Status and Vision Profile and showed that LASIK significantly improved vision-related psychological concern and physical function. Awwad et al evaluated psychological and role/social QOL in 30 myopic subjects who underwent wavefront-guided LASIK using another survey based on four vision-related QOL questionnaires: the National Eye Institute Refractive Error Quality of Life, the Refractive Status and Vision Profile, the Quality of Life Impact of Refractive Correction, and the Myopia-Specific Quality of Life. In this study, the authors showed that the indicators of psychological well-being, such as energy level, stress level, self-confidence, self-esteem, expectation for the future, and sense of safety, were each significantly improved (10%--25%) after LASIK.[@b9-opth-10-1859] Lee et al[@b5-opth-10-1859] examined QOL change following LASIK using the Myopia-Specific Quality of Life Questionnaire and reported that LASIK improved the psychological well-being score by 36%. However, Lazon et al[@b10-opth-10-1859] evaluated multidimensional QOL using the Institute for Eye Research's multidimensional QOL scale before and after LASIK, but was unable to detect a statistical difference. Therefore, in agreement with our results, the majority of studies have demonstrated a positive effect of LASIK on mental HRQoL. Importantly, however, the questionnaires used in previous studies were based on vision-related QOL, which may be predicted to be directly affected by vision improvement surgery.[@b5-opth-10-1859],[@b8-opth-10-1859]--[@b11-opth-10-1859] In our study, we used a nonvision-related health questionnaire to convincingly demonstrate that LASIK improves mental HRQoL.

Surprisingly, no significant improvement was observed in HRQoL after 6 months of LASIK, although neither the visual outcome nor the satisfaction rate changed significantly between 1 month and 6 months after surgery. More than 90% of the subjects were satisfied with LASIK after 6 months of surgery. The adaptation theory of well-being, which posits that good and bad events temporarily affect happiness, but people quickly adapt back to hedonic neutrality after 6--12 months of the event, may explain the results.[@b12-opth-10-1859] Suh et al[@b13-opth-10-1859] found that good and bad life events affected happiness only if they occurred in the past 2 months. In this case, the postoperative MCS score would revert back toward the preoperative score by 6 months post LASIK.

The preoperative MCS score in our study was 51.0. The average age of subjects in our study was 36.0 years. The average MCS score for 20-to-29-year-old and 30-to-39-year-old Japanese subjects was 48.4 and 48.8, respectively. Therefore, the MCS score in our study is slightly higher but overall comparable with the Japanese norm.[@b6-opth-10-1859],[@b7-opth-10-1859] The preoperative PCS score in our study was 56.2. The average PCS scores for 20--29-year-old and 30--39-year-old Japanese subjects were 56.1 and 53.6, respectively.[@b6-opth-10-1859],[@b7-opth-10-1859] Together, this suggests that our data are reasonable and compatible with those of the normal Japanese population.

Severity of halo, glare, double vision, asthenopia, and low satisfaction of LASIK 1 month after surgery were significantly associated with decreased MCS score. These results suggest that reduced QOL is associated with reduced mental HRQoL. Delta MCS was significantly associated with preoperative spherical equivalent and axial length in the univariate and multivariate analyses in both subject groups. This result suggests that myopic patients who have severe myopia may experience reduced mental HRQoL after LASIK.

This study is subject to several limitations. First, we were unable to gather data from every subject who underwent LASIK, which may introduce bias. Second, information about education, marital status, and income, each of which is a potentially confounding factor, was not collected or analyzed in this study. Another limitation of our study is that 50% of our 1-month eyes did not provide 6 months data. Long-term result would be valuable such as week data.

This study can conclude that quality of life is not lost with LASIK.

LASIK may improve mental HRQoL. Both preoperative axial length and spherical equivalent may be a predictor of change in the MCS score after LASIK. Poorer postoperative quality of vision is associated with lower mental HRQoL.
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###### 

Demographic characteristics of subjects who underwent LASIK

  Variables                                                             Mean ± SD or number   Range or proportion
  --------------------------------------------------------------------- --------------------- ------------------------
  Age (years)                                                           36.0±11.0             20--65
  Sex (male/female)                                                     72/141                34%/66%
  Smoking status (never/previous/current)                               138/50/23             65%/24%/11%
  Alcohol intake (never/sometimes/often)                                70/115/28             33%/54%/13%
  Type of refractive error correction (SCL/HCL/glasses/no correction)   150/30/27/6           70.4%/14.1%/12.7%/2.8%
  Period of CL use (years)                                              14.4±7.5              1.0--38.0
  BCVA in the right eye (logMAR)                                        −0.12±0.11            −0.3--0.7
  Pupil diameter right eye (mm)                                         6.28±0.83             3.25--8.16
  Axial length right eye (mm)                                           25.85±1.13            23.25--29.54

**Abbreviations:** LASIK, laser in situ keratomileusis; SD, standard deviation; SCL, soft contact lens; HCL, hard contact lens; CL, contact lens; BCVA, best-corrected visual acuity; logMAR, logarithm of the minimum angle of resolution; NCVA, noncorrected visual acuity; BUT, tear break-up time.

###### 

Change in parameters before versus after LASIK

  Variables                      Preoperative   1 month      6 months     *P*-value
  ------------------------------ -------------- ------------ ------------ -----------
  Overall subjects                                                        
   UCVA right eye (logMAR)       1.16±0.32      −0.11±0.15   −0.09±0.15   \<0.001
   Sph right eye (diopter)       −5.90±2.49     −0.39±0.55   −0.46±0.50   \<0.001
   BUT right eye (seconds)       3.9±1.8        3.0±1.6      --           \<0.001
   Fluorescein score right eye   0.35±0.72      0.44±0.85    --           0.22
  Healthy subjects                                                        
   UCVA right eye (logMAR)       1.16±0.32      −0.11±0.15   −0.09±0.15   \<0.001
   Sph right eye (diopter)       −5.89±2.49     −0.39±0.55   −0.46±0.50   \<0.001
   BUT right eye (seconds)       3.9±1.8        3.0±1.6      --           \<0.001
   Fluorescein score right eye   0.35±0.72      0.44±0.85    --           0.22

**Abbreviations:** LASIK, laser in situ keratomileusis; UCVA, uncorrected visual acuity; logMAR, logarithm of the minimum angle of resolution; Sph, spherical equivalent; BUT, tear break-up time.

###### 

Changes in PCS and MCS after LASIK

                     Preoperative   1 month                                                 6 months   *P*-value
  ------------------ -------------- ------------------------------------------------------- ---------- -----------
  Overall subjects                                                                                     
   PCS               56.2±6.7       56.7±6.0                                                55.9±6.9   0.53
   MCS               51.0±9.4       52.0±9.8[\*](#tfn4-opth-10-1859){ref-type="table-fn"}   51.5±9.6   0.03
  Healthy subjects                                                                                     
   PCS               57.3±6.6       57.4±5.6                                                56.7±8.1   0.85
   MCS               52.3±9.4       53.3±9.8[\*](#tfn4-opth-10-1859){ref-type="table-fn"}   52.2±9.8   0.01

**Notes:** Data shown as mean ± standard deviation.

MCS 1 month after LASIK is significantly higher than preoperative MCS (overall subjects: *P*=0.03; healthy subjects: *P*=0.02).

**Abbreviations:** PCS, physical component summary; MCS, mental component summary; LASIK, laser in situ keratomileusis.

###### 

Preoperative factors analyzed in association with delta MCS 1 month after LASIK

  Independent variables                                                        Overall subjects   Healthy subjects                                              
  ---------------------------------------------------------------------------- ------------------ --------------------------------------------------- --------- ------------------------------------------------------
  Age (years)                                                                  −0.068             0.39                                                −0.036    0.69
  Sex (ref female)                                                             0.132              0.10                                                0.121     0.19
  Axial length[a](#tfn7-opth-10-1859){ref-type="table-fn"} (mm)                −0.167             0.03[\*](#tfn8-opth-10-1859){ref-type="table-fn"}   --0.260   0.003[\*\*](#tfn9-opth-10-1859){ref-type="table-fn"}
  Spherical equivalent[a](#tfn7-opth-10-1859){ref-type="table-fn"} (diopter)   0.182              0.01[\*](#tfn8-opth-10-1859){ref-type="table-fn"}   0.296     0.001[\*\*](#tfn9-opth-10-1859){ref-type="table-fn"}
  BUT (seconds)                                                                0.055              0.50                                                0.045     0.63
  Fluorescein score                                                            0.052              0.51                                                0.056     0.54
  Pupil diameter (mm)                                                          0.008              0.92                                                0.008     0.93
  Prevalence of systemic disease (yes or no)                                   −0.04              0.58                                                --        --

**Notes:** Vision-related values in the right eye were used. Factors associated with delta MCS did not change after using vision-related factors in the left eye as independent variables.

When spherical equivalent was used as an independent variable, axial length was not used as an independent variable.

*P*\<0.05.

*P*\<0.01.

**Abbreviations:** MCS, mental summary component; LASIK, laser in situ keratomileusis; BUT, tear break-up time; ref, reference.

###### 

Postoperative factors analyzed in association with delta MCS 1 month after LASIK

  Independent variables            Overall subjects   Healthy subjects                                                 
  -------------------------------- ------------------ ------------------------------------------------------- -------- -------------------------------------------------------
  Spherical equivalent (diopter)   −0.021             0.81                                                    0.137    0.31
  BUT (seconds)                    −0.011             0.90                                                    0.043    0.77
  Fluorescein score                −0.020             0.82                                                    0.136    0.34
  Quality of far vision            −0.196             0.016[\*](#tfn12-opth-10-1859){ref-type="table-fn"}     −0.242   0.007[\*\*](#tfn13-opth-10-1859){ref-type="table-fn"}
  Quality of near vision           0.007              0.94                                                    −0.04    0.70
  Halo                             −0.199             0.017[\*](#tfn12-opth-10-1859){ref-type="table-fn"}     −0.284   0.003[\*\*](#tfn13-opth-10-1859){ref-type="table-fn"}
  Glare                            −0.159             0.045[\*](#tfn12-opth-10-1859){ref-type="table-fn"}     −0.224   0.012[\*](#tfn12-opth-10-1859){ref-type="table-fn"}
  Double vision                    −0.224             0.005[\*\*](#tfn13-opth-10-1859){ref-type="table-fn"}   −0.356   0.001[\*\*](#tfn13-opth-10-1859){ref-type="table-fn"}
  Asthenopia                       −0.167             0.033[\*](#tfn12-opth-10-1859){ref-type="table-fn"}     −0.250   0.004[\*\*](#tfn13-opth-10-1859){ref-type="table-fn"}
  Dry eye sensation                −0.119             0.14                                                    −0.196   0.03[\*](#tfn12-opth-10-1859){ref-type="table-fn"}
  Satisfaction of LASIK            −0.204             0.012[\*](#tfn12-opth-10-1859){ref-type="table-fn"}     −0.257   0.004[\*\*](#tfn13-opth-10-1859){ref-type="table-fn"}

**Notes:** These independent variables were adjusted by age, sex, axial length, BUT, pupil diameter, and fluorescein score in the right eye. Factors associated with delta MCS did not change after using factors in the left eye as independent variables. Each of the subjective symptoms were nested.

*P*\<0.05.

*P*\<0.01.

**Abbreviations:** MCS, mental summary component; LASIK, laser in situ keratomileusis; BUT, tear break-up time.
